ImmunoGen’s Elahere Wins Big In Confirmatory Ovarian Cancer Trial

 
• By Alaric DeArment
  
ImmunoGen announced data from the Phase III MIRASOL trial of Elahere in ovarian cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D